Clinical effectiveness of bevacizumab in patients with recurrent brain tumours: A population-based evaluation
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155216681191
Abstract: Background Bevacizumab is an antiangiogenic agent active in patients with recurrent malignant gliomas. However, evidence for its clinical efficacy is relatively limited so that bevacizumab is approved for this indication in Canada and the United… read more here.
Keywords: bevacizumab; progression; patients recurrent; effectiveness bevacizumab ... See more keywords